Disease
|
Drug/Important Bio-Agent (IBA)
4 | Analgesics (Analgesic Drugs)IBA
06/2009
-
09/2006 |
3 | CannabinoidsIBA
06/2009
-
01/2008 |
2 | CB2 Cannabinoid ReceptorIBA
01/2008
-
09/2006 |
1 | Cannabinoid Receptor AgonistsIBA
06/2009 |
1 | (3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
06/2009 |
1 | ZymosanIBA
05/2009 |
1 | 4- piperazin- 1- yl- 6,7- dihydro- 5H- benzo(6,7)cyclohepta(1,2- d)pyrimidin- 2- ylamineIBA
05/2009 |
1 | CalciumIBA
05/2009 |
1 | Histamine H4 ReceptorsIBA
05/2009 |
1 | Prostaglandin D2IBA
05/2009 |
1 | (1- (2- morpholin- 4- yl- ethyl)- 1H- indol- 3- yl)- (2,2,3,3- tetramethylcyclopropyl)methanoneIBA
01/2008 |
1 | mu Opioid Receptors (mu Opioid Receptor)IBA
01/2008 |
1 | Histamine H3 Receptors (Histamine H3 Receptor)IBA
04/2005 |
1 | LigandsIBA
05/2003 |
1 | Neurotransmitter Agents (Neurotransmitter)IBA
05/2003 |
1 | Histamine (Histamine Dihydrochloride)FDA Link
05/2003 |
|